Intranasal bioavailability of diazepam in sheep correlated to rabbit and man

International Journal of Pharmaceutics

Volumn 231, Issue 1, 2002, Pages 67-72

  Lindhardt, Karsten ^a   Ólafsson, David R ^b   Gizurarson, Sveinbjörn ^b,c   Bechgaard, Erik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Lyfjathroun Biopharmaceuticals   (Iceland)

^c UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; MACROGOL;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; EMERGENCY TREATMENT; HUMAN; NONHUMAN; PRIORITY JOURNAL; RABBIT; SHEEP; SPECIES DIFFERENCE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-ANXIETY AGENTS; BIOLOGICAL AVAILABILITY; DIAZEPAM; HUMANS; RABBITS; SHEEP;

EID: 0035179796     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(01)00872-9     Document Type: Article

References (9)

1. Pharmacokinetic and pharmacodynamic response after intranasal administration of diazepam to rabbits
2. Animal models for intranasal drug delivery studies
3. Intranasal administration of diazepam aiming at the treatment of acute seizures: Clinical trials in healthy volunteers
4. Nasal delivery. The use of animal models to predict performance in man
5. Rapid-onset intranasal delivery of anticonvulsants: Pharmacokinetic and pharmacodynamic evaluation in rabbits
6. Intranasal absorption of buprenorphine- in vivo bioavailability study
7. Electroencephalographic effects and blood levels after intranasal administration of diazepam to humans
8. Intranasal bioavailability of buprenorphine in rabbit correlated to sheep and man